P

Inventor

QIAN XUEMING

US12 patents
⚠️ This page may combine multiple inventors who share the name “QIAN XUEMING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AMGEN INC

3 patents
US7438910B2Oct 21, 2008

Therapeutic human anti-IL1-R1 monoclonal antibody

AMGEN INC54 citations94
US8043620B2Oct 25, 2011

Wise binding agents and epitopes

AMGEN INC13 citations82
US8710203B2Apr 29, 2014

Therapeutic human anti-IL-1R1 monoclonal antibody

AMGEN INC0 citations47

JIANGSU HENGRUI MEDICINE CO

2 patents
US11525005B2Dec 13, 2022

Anti-CD40 antibody, antigen binding fragment thereof and medical use thereof

JIANGSU HENGRUI MEDICINE CO1 citations60
US12162944B2Dec 10, 2024

Human IL-4R binding antibody, antigen binding fragment thereof, and medical use thereof

JIANGSU HENGRUI MEDICINE CO0 citations49

VARNUM BRIAN

2 patents
US8518407B2Aug 27, 2013

Therapeutic human anti-IL-1R1 monoclonal antibody

VARNUM BRIAN2 citations58
US8236559B2Aug 7, 2012

Therapeutic human anti-IL-1R1 monoclonal antibody

VARNUM BRIAN1 citations58

MEDAREX LLC

1 patent
US9534053B2Jan 3, 2017

Therapeutic human anti-IL-1R1 monoclonal antibody

MEDAREX LLC2 citations70

QIAN XUEMING

1 patent
US8309092B2Nov 13, 2012

Wise binding agents and epitopes

QIAN XUEMING2 citations54

SUZHOU TRANSCENTA THERAPEUTICS CO LTD

1 patent
US11753473B2Sep 12, 2023

Anti-PD-L1 antibodies

SUZHOU TRANSCENTA THERAPEUTICS CO LTD0 citations52

BEIJING SHENOGEN PHARMA GROUP LTD

1 patent
US10233249B2Mar 19, 2019

Antibodies and methods for treating estrogen receptor-associated diseases

BEIJING SHENOGEN PHARMA GROUP LTD0 citations46

MABSPACE BIOSCIENCES SUZHOU CO LTD

1 patent
US10822416B2Nov 3, 2020

Anti-PD-L1 antibodies

MABSPACE BIOSCIENCES SUZHOU CO LTD0 citations42